The Journal of Organic Chemistry
Article
132.2, 129.6, 129.5, 128.9, 127.5, 126.9, 125.9, 118.5, 114.2, 55.4
ppm.
2.47 (s, 3H), 1.38−1.35 (t, 3H); 13C{1H} NMR (CDCl3, 100 MHz):
δ 154.1, 141.3, 129.8, 125.7, 123.3, 123.0, 122.0, 121.6, 120.3, 28.9,
22.4, 13.7 ppm.
2-(4-(Methylthio)phenyl)quinolone (2g). White solid (201 mg,
80%); eluent combination: hexane/ethyl acetate (10:1). Spectro-
scopic data matched with those reported in the literature.37 1H NMR
(CDCl3, 400 MHz): δ 8.21−8.11 (m, 4H), 7.86−7.81 (m, 2H),
7.74−7.71 (t, 1H), 7.53−7.50 (t, 1H), 7.40−7.38 (d, 2H), 2.55 (s,
3H); 13C{1H} NMR (CDCl3, 100 MHz): δ 156.7, 148.4, 140.5,
136.8, 136.4, 129.8, 129.7, 127.9, 127.5, 126.5, 126.3, 118.7, 15.6
ppm.
2-(4-(Trifluoromethyl)phenyl)quinoline (2h). White solid
(205 mg, 75%); eluent combination: hexane/ethyl acetate (10:1).
Spectroscopic data matched with those reported in the literature.15b
1H NMR (CDCl3, 400 MHz): δ 8.29−8.26 (t, 3H), 8.20−8.18 (d,
1H), 7.90−7.89 (m, 2H), 7.79−7.78 (m, 3H), 7.57 (t, 1H); 13C{1H}
NMR (CDCl3, 100 MHz): δ 155.8, 148.4, 143.1, 137.2, 130.1, 130.0,
128.0, 127.6, 127.0, 125.9, 125.8, 118.9; 19F NMR (CDCl3, 376
MHz): δ −61.2 ppm.
2-(Pyridin-2-yl)quinoline (2i). Pale-yellow solid (160 mg, 78%);
eluent combination: hexane/ethyl acetate (10:1). Spectroscopic data
matched with those reported in the literature.10 1H NMR (CDCl3,
400 MHz): δ 8.76 (d, 1H), 8.68 (dt, 1H), 8.59 (d, 1H), 8.29 (d, 1H),
8.21 (d, 1H), 7.90−7.85 (m, 2H), 7.75 (m, 1H), 7.56 (m, 1H), 7.36
(m, 1H); 13C{1H} NMR (CDCl3, 100 MHz): δ 152.1, 144.1, 142.1,
141.1, 136.4, 133.9, 131.5, 131.0, 120.5, 129.3, 123.4 ppm.
2-(Thiophen-2-yl)quinoline (2j). White solid (171 mg, 81%);
eluent combination: hexane/ethyl acetate (10:1). Spectroscopic data
matched with those reported in the literature.10 1H NMR (CDCl3,
400 MHz): δ 8.14−8.08 (m, 2H), 7.80−7.76 (m, 2H), 7.74−7.68 (m,
2H), 7.51−7.46 (m, 2H), 7.17−7.15 (dd, 1H); 13C{1H} NMR
(CDCl3, 100 MHz): δ 153.6, 145.2, 133.7, 126.7, 12.6, 124.8, 124.4,
123.4, 123.1, 115.5 ppm.
2-Cyclopropylquinoline (2k). Colorless oil (116 mg, 69%);
eluent combination: hexane/ethyl acetate (15:1). Spectroscopic data
matched with those reported in the literature.13 1H NMR (CDCl3,
400 MHz): δ 7.99−7.95 (m, 2H), 7.72−7.70 (d, 1H), 7.66−7.62 (m,
1H), 7.44−7.40 (t, 1H), 7.14−7.12 (d, 1H), 2.27−2.21 (m, 1H),
1.19−1.15 (m, 2H), 1.11−1.08 (m, 2H); 13C{1H} NMR (CDCl3, 100
MHz): δ 163.3, 147.8, 135.7, 129.1, 128.5, 127.3, 126.6, 125.0, 119.2,
18.0, 10.2 ppm.
3-Methoxy-5,6-dihydrobenzo[c]acridine (2p). Light yellow
solid (167 mg, 64%); eluent combination: hexane/ethyl acetate
(15:1). Spectroscopic data matched with those reported in the
literature.38 1H NMR (CDCl3, 400 MHz): δ 8.20−8.18 (d, 2H), 7.86
(s, 1H), 7.73−7.65 (m, 2H), 7.49−7.46 (m, 1H), 7.20−7.18 (m, 1H),
6.99−6.96 (m, 1H), 3.98 (s, 3H), 3.06 (t, 2H), 2.94−2.92 (m, 2H)
ppm; 13C{1H} NMR (CDCl3, 100 MHz): δ 159.0, 153.2, 147.5,
135.6, 133.7, 131.8, 130.6, 129.3, 129.0, 128.6, 127.9, 126.9, 126.0,
116.9, 109.6, 55.5, 29.0, 27.5 ppm.
2-Methyl-1,2,3,4-tetrahydroacridine (2q). Yellow solid (144
mg, 73%); eluent combination: hexane/ethyl acetate (15:1).
Spectroscopic data matched with those reported in the literature.38
1H NMR (CDCl3, 400 MHz): δ 7.97−7.96 (m, 1H), 7.74 (s, 1H),
7.67−7.65 (m, 1H), 7.60−7.57 (m, 1H), 7.42−7.39 (m, 1H), 3.24−
3.18 (m, 1H), 3.12−2.96 (m, 2H), 2.59−2.53 (m, 1H), 2.07−2.02
(m, 2H), 1.60−1.56 (m, 1H), 1.11−1.10 (d, 3H) ppm; 13C{1H}
NMR (CDCl3, 100 MHz): δ 159.0, 146.7, 135.0, 130.6, 128.5, 128.3,
127.2, 126.9, 125.5, 37.8, 33.1, 31.4, 29.1, 21.7 ppm.
2-tert-Butyl-1,2,3,4-tetrahydroacridine (2r). Light yellow solid
(179 mg, 75%); eluent combination: hexane/ethyl acetate (15:1).
Spectroscopic data matched with those reported in the literature.38 1H
NMR (CDCl3, 400 MHz): δ 7.99−7.96 (m, 1H), 7.82 (s, 1H), 7.71−
7.68 (m, 1H), 7.63−7.57 (m, 1H), 7.45−7.40 (m, 1H), 3.32−3.23
(m, 1H), 3.11−3.01 (m, 2H), 2.77−2.72 (m, 1H), 2.20−2.12 (m,
1H), 1.65−1.52 (m, 2H), 1.00 (s, 9H) ppm; 13C{1H} NMR (CDCl3,
100 MHz): δ 159.5, 146.6, 135.4, 131.3, 128.6, 128.3, 127.2, 126.9,
125.6, 44.7, 34.3, 32.6, 30.8, 27.3, 24.6 ppm.
2-(2-Chlorophenyl)quinoline (2s). White solid (182 mg, 76%);
eluent combination: hexane/ethyl acetate (10:1). Spectroscopic data
matched with those reported in the literature.33a 1H NMR (CDCl3,
400 MHz): δ 8.24−8.17 (m, 2H), 7.89−7.87 (d, 1H), 7.76−7.74 (t,
2H), 7.71−7.69 (d, 1H) 7.61−7.57 (d, 1H), 7.44−7.42 (d, 1H),
7.40−7.37 (m, 2H); 13C{1H} NMR (CDCl3, 100 MHz): δ 135.8,
131.8, 130.2, 130.0, 129.8, 127.7, 127.3, 126.9, 122.9 ppm.
Quinoxaline (3a). White solid (119 mg, 92%); eluent
combination: hexane/ethyl acetate (10:1). Spectroscopic data
matched with those reported in the literature.31 1H NMR (CDCl3,
400 MHz): δ 8.79 (s, 2H), 8.07−8.03 (m, 2H), 7.72−7.70 (m, 2H);
13C{1H} NMR (CDCl3, 100 MHz): δ 145.4, 143.4, 130.5, 129.9.
6-Chloroquinoxaline (3b). Brown solid (139 mg, 85%); eluent
combination: hexane/ethyl acetate (10:1). Spectroscopic data
matched with those reported in the literature.39 1H NMR (CDCl3,
400 MHz): δ 8.85−8.83 (d, 2H), 8.11−8.10 (d, 1H), 8.06−8.04 (d,
1H), 7.74−7.71 (d, 1H); 13C{1H} NMR (CDCl3, 100 MHz): δ 146.0,
145.3, 143.5, 141.7, 136.1, 131.4, 131.0, 128.6 ppm.
2,3-Dihydro-1H-cyclopenta[b]quinolone (2l). Light yellow oil
(120 mg, 71%); eluent combination: hexane/ethyl acetate (15:1).
Spectroscopic data matched with those reported in the literature.13 1H
NMR (CDCl3, 400 MHz): δ 8.04−8.02 (d, 1H), 7.81 (s, 1H), 7.67−
7.65 (d, 1H), 7.59−7.55 (t, 1H), 7.41−7.37 (t, 1H), 3.18−3.08 (m,
4H), 2.08−2.03 (t, 2H) ppm; 13C{1H} NMR (CDCl3, 100 MHz): δ
163.7, 150.9, 139.4, 135.4, 132.9, 132.6, 131.6, 131.3, 129.9, 37.9,
33.6, 27.3 ppm.
1,2,3,4-Tetrahydroacridine (2m). Light yellow oil (150 mg,
82%); eluent combination: hexane/ethyl acetate (15:1). Spectro-
scopic data matched with those reported in the literature.13 1H NMR
(CDCl3, 400 MHz): δ 7.98−7.96 (d, 1H), 7.78 (s, 1H), 7.69−7.67
(d, 1H), 7.59−7.57 (m, 1H), 7.44−7.40 (m, 1H), 3.14−3.11 (t, 2H),
2.98−2.94 (t, 2H), 1.99−1.97 (m, 2H), 1.89−1.88 (m, 2H) ppm;
13C{1H} NMR (CDCl3, 100 MHz): δ 159.4, 146.6, 135.1, 131.0,
128.6, 128.3, 127.3, 126.9, 125.6, 33.6, 29.3, 23.3, 23.0 ppm.
7,8,9,10-Tetrahydro-6H-cyclohepta[b]quinoline (2n). White
solid (134 mg, 68%); eluent combination: hexane/ethyl acetate
(15:1). Spectroscopic data matched with those reported in the
literature.13 1H NMR (CDCl3, 400 MHz): δ 8.00−7.98 (d, 1H), 7.73
(s, 1H), 7.66−7.64 (d, 1H), 7.58−7.57 (t, 1H), 7.42−7.39 (t, 1H),
3.19−3.16 (m, 2H), 2.87−2.86 (m, 2H), 1.85−1.84 (m, 2H), 1.76−
1.69 ppm (m, 4H). 13C{1H} NMR (CDCl3, 100 MHz): δ 160.9,
148.1, 136.9, 132.8, 130.0, 129., 128.7, 128.4, 127.1, 31.4, 29.1, 27.8,
22.3, 13.9 ppm.
6-Bromoquinoxaline (3c). White solid (159 mg, 76%); eluent
combination: hexane/ethyl acetate (10:1). Spectroscopic data
matched with those reported in the literature.40 1H NMR (CDCl3,
400 MHz): δ 8.77 (s, 2H), 8.20 (s, 1H), 7.90−7.87 (d, 1H), 7.77−
7.75 (d, 1H); 13C{1H} NMR (CDCl3, 100 MHz): δ 145.6, 145.1,
143.4, 141.6, 133.6, 131.7, 130.8, 124.0 ppm.
6-Methylquinoxaline (3d). Orange oil (111 mg, 77%); eluent
combination: hexane/ethyl acetate (10:1). Spectroscopic data
matched with those reported in the literature.39 1H NMR (CDCl3,
400 MHz): δ 8.70−8.67 (d, 2H), 7.91−7.88 (d, 1H), 7.77 (s, 1H),
7.50−7.48 (d, 1H), 2.49 (s, 3H); 13C{1H} NMR (CDCl3, 100 MHz):
δ 144.8, 144.0, 142.9, 141.4, 140.6, 132.3, 128.9, 128.1, 21.8 ppm.
6-Methoxyquinoxaline (3e). Yellow solid (110 mg, 69%); eluent
combination: hexane/ethyl acetate (10:1). Spectroscopic data
matched with those reported in the literature.39 1H NMR (CDCl3,
400 MHz): δ 8.75 (s, 1H), 8.69 (s, 1H), 7.99−7.96 (d, 1H), 7.43−
7.41 (d, 1H), 7.37 (s, 1H), 3.97 (s, 3H); 13C{1H} NMR (CDCl3, 100
MHz): δ 160.9, 145.0, 144.7, 142.5, 139.3, 130.5, 123.6, 106.7, 55.9
ppm.
3-Ethyl-2-methylquinoline (2o). Light yellow oil (121 mg,
71%), eluent combination: hexane/ethyl acetate (15:1). Spectro-
scopic data matched with those reported in the literature.11 1H NMR
(CDCl3, 400 MHz): δ 8.03−8.01 (d, 1H), 7.81 (s, 1H), 7.69−7.67
(d, 1H), 7.62−7.58 (m, 1H), 7.45−7.41 (m, 1H), 3.01−2.96 (t, 2H),
2-Phenylquinoxaline (3f). Yellow oil (146 mg, 71%); eluent
combination: hexane/ethyl acetate (10:1). Spectroscopic data
matched with those reported in the literature.32 1H NMR (CDCl3,
F
J. Org. Chem. XXXX, XXX, XXX−XXX